Posted by ABMN Staff on Apr 23rd, 2024
Kane Biotech Inc. (CVE:KNE – Get Free Report) Director Philip Renaud sold 2,000,000 shares of Kane Biotech stock in a transaction that occurred on Wednesday, April 17th. The shares were sold at an average price of C$0.13, for...
More of this article »